基于CYP2C19基因型指导的质子抑制剂剂量:临床试验和现实世界的使用进展
相关实验视频
Updated: Feb 1, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
Han Minh Thuy1,2, Mitsushige Sugimoto3, Pham Minh Ngoc Quang1,4
1Department of Environmental and Preventive Medicine, Oita University, Yufu, Japan.
Expert review of clinical pharmacology
|January 31, 2026
概括
基因型导向的质子抑制剂 (PPI) 疗法通过考虑单个细胞染色体P450 2C19 (CYP2C19) 遗传变异来优化与酸相关疾病的治疗,从而提高疗效和安全性.
科学领域:
- 药物基因组学 药物基因组学
- 胃肠病学 胃肠病学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 质子抑制剂 (PPI) 对与酸有关的疾病至关重要.
- 个人对PPI的反应因细胞染色体P450 2C19 (CYP2C19) 遗传多态性而有所不同.
- 这种变化会影响治疗的有效性和安全性,导致潜在的治疗失败.
研究的目的:
- 对成人和儿童的CYP2C19引导PPI治疗的证据进行审查.
- 评估基因型导向治疗对诸如GERD,H. pylori根除和eosinophilic食道炎等疾病的影响.
- 探索个性化PPI治疗的障碍和未来方向.
主要方法:
- 临床试验和元分析的系统审查.
- 在PubMed的文献搜索和临床指南 (1989-2025).
- 专注于PPI的CYP2C19介导的药理动力学和药理动力学.
主要成果:
- 基因型导向的PPI治疗可以提高治疗疗效和症状控制.
- 量身定制治疗包括剂量调整,药物选择或治疗方案修改.
- 目前的证据表明,与指导治疗相关的安全风险或成本没有增加.
结论:
- CYP2C19基因型导向疗法是针对酸性相关疾病的个性化药物的实用方法.
- 实施障碍包括测试可用性,成本效益和临床医生的意识.
- 未来的进展可能涉及多基因测试,人工智能和基于模型的剂量用于个性化的酸抑制.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
943
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
943
Clinical Trials
10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.4K
Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
ATP Driven Pumps III: V-type Pumps
4.8K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.8K

